$1.55 EPS Expected for Walgreens Boots Alliance, Inc. (WBA)

March 14, 2018 - By Marry Poplack

 $1.55 EPS Expected for Walgreens Boots Alliance, Inc. (WBA)

Analysts expect Walgreens Boots Alliance, Inc. (NASDAQ:WBA) to report $1.55 EPS on March, 28 before the open.They anticipate $0.19 EPS change or 13.97 % from last quarter’s $1.36 EPS. WBA’s profit would be $1.54B giving it 11.06 P/E if the $1.55 EPS is correct. After having $1.28 EPS previously, Walgreens Boots Alliance, Inc.’s analysts see 21.09 % EPS growth. The stock decreased 1.88% or $1.31 during the last trading session, reaching $68.55. About 4.29M shares traded. Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has risen 5.77% since March 15, 2017 and is uptrending. It has underperformed by 10.93% the S&P500.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Ratings Coverage

Among 22 analysts covering Walgreens Boots Alliance (NASDAQ:WBA), 13 have Buy rating, 1 Sell and 8 Hold. Therefore 59% are positive. Walgreens Boots Alliance had 55 analyst reports since August 24, 2015 according to SRatingsIntel. On Tuesday, January 9 the stock rating was maintained by Needham with “Buy”. UBS maintained Walgreens Boots Alliance, Inc. (NASDAQ:WBA) on Wednesday, August 23 with “Buy” rating. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) has “Buy” rating given on Thursday, July 20 by Leerink Swann. The stock of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) earned “Buy” rating by Bank of America on Tuesday, June 7. The company was initiated on Friday, January 22 by Robert W. Baird. The rating was upgraded by RBC Capital Markets on Wednesday, October 28 to “Buy”. The stock has “Outperform” rating by Credit Suisse on Thursday, September 1. Barclays Capital reinitiated the stock with “Equal-Weight” rating in Thursday, March 10 report. The rating was maintained by Credit Suisse with “Outperform” on Monday, July 18. Wood downgraded the shares of WBA in report on Friday, July 22 to “Underperform” rating.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The company has market cap of $67.91 billion. It operates through three divisions: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. It has a 18.91 P/E ratio. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.

More notable recent Walgreens Boots Alliance, Inc. (NASDAQ:WBA) news were published by: Businesswire.com which released: “Rite Aid Announces Continued Progress in Sale of Assets to Walgreens Boots …” on March 05, 2018, also Seekingalpha.com with their article: “Walgreens Boots Alliance – What Keeps The Stock From Going Up?” published on March 12, 2018, Nasdaq.com published: “Walgreens Boots Alliance, Inc. (WBA) Ex-Dividend Date Scheduled for February …” on February 13, 2018. More interesting news about Walgreens Boots Alliance, Inc. (NASDAQ:WBA) were released by: Zacks.com and their article: “Should Value Investors Pick Walgreens Boots Alliance (WBA) Stock?” published on February 27, 2018 as well as Seekingalpha.com‘s news article titled: “Walgreens Boots Alliance appoints James Kehoe Global CFO” with publication date: March 08, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: